Literature DB >> 29978359

Testosterone, myocardial function, and mortality.

Vittorio Emanuele Bianchi1.   

Abstract

The cardiovascular system is particularly sensitive to androgens, but some controversies exist regarding the effect of testosterone on the heart. While among anabolic abusers, cases of sudden cardiac death have been described, recently it was reported that low serum level of testosterone was correlated with increased risk of cardiovascular diseases (CVD) and mortality rate. This review aims to evaluate the effect of testosterone on myocardial tissue function, coronary artery disease (CAD), and death. Low testosterone level is associated with increased incidence of CAD and mortality. Testosterone administration in hypogonadal elderly men and women has a positive effect on cardiovascular function and improved clinical outcomes and survival time. Although at supraphysiologic doses, androgen may have a toxic effect, and at physiological levels, testosterone is safe and exerts a beneficial effect on myocardial function including mechanisms at cellular and mitochondrial level. The interaction with free testosterone and estradiol should be considered. Further studies are necessary to better understand the interaction mechanisms for an optimal androgen therapy in CVD.

Entities:  

Keywords:  Cardiac mitochondria; Cardiomyocytes; Cardiovascular disease; Cardiovascular mortality; Coronary artery disease; Heart failure; Testosterone

Mesh:

Substances:

Year:  2018        PMID: 29978359     DOI: 10.1007/s10741-018-9721-0

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  189 in total

1.  In older men, higher plasma testosterone or dihydrotestosterone is an independent predictor for reduced incidence of stroke but not myocardial infarction.

Authors:  Bu B Yeap; Helman Alfonso; S A Paul Chubb; Graeme J Hankey; David J Handelsman; Jonathan Golledge; Osvaldo P Almeida; Leon Flicker; Paul E Norman
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

2.  Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.

Authors:  Olga M Calof; Atam B Singh; Martin L Lee; Anne M Kenny; Randall J Urban; Joyce L Tenover; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-11       Impact factor: 6.053

3.  Testosterone level and mortality in elderly men with systolic chronic heart failure.

Authors:  Hai-Yun Wu; Xiao-Fei Wang; Jun-Hua Wang; Jiang-Yuan Li
Journal:  Asian J Androl       Date:  2011-06-20       Impact factor: 3.285

4.  Testosterone, dihydrotestosterone and estradiol are differentially associated with carotid intima-media thickness and the presence of carotid plaque in men with and without coronary artery disease.

Authors:  Yi X Chan; Matthew W Knuiman; Joseph Hung; Mark L Divitini; David J Handelsman; John P Beilby; Brendan McQuillan; Bu B Yeap
Journal:  Endocr J       Date:  2015-06-13       Impact factor: 2.349

Review 5.  Contribution of impaired mitochondrial autophagy to cardiac aging: mechanisms and therapeutic opportunities.

Authors:  Debapriya Dutta; Riccardo Calvani; Roberto Bernabei; Christiaan Leeuwenburgh; Emanuele Marzetti
Journal:  Circ Res       Date:  2012-04-13       Impact factor: 17.367

6.  Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptor.

Authors:  Joanne E Nettleship; T Hugh Jones; Kevin S Channer; Richard D Jones
Journal:  Circulation       Date:  2007-11-05       Impact factor: 29.690

7.  Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men from the Framingham Heart Study.

Authors:  Robin Haring; Zhaoyang Teng; Vanessa Xanthakis; Andrea Coviello; Lisa Sullivan; Shalender Bhasin; Joanne M Murabito; Henri Wallaschofski; Ramachandran S Vasan
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04       Impact factor: 3.478

Review 8.  Testosterone, SHBG and cardiovascular health in postmenopausal women.

Authors:  J S Brand; Y T van der Schouw
Journal:  Int J Impot Res       Date:  2010-01-21       Impact factor: 2.896

9.  Estrogen modulates cardiac growth through an estrogen receptor α-dependent mechanism in healthy ovariectomized mice.

Authors:  Georgios Kararigas; Ba Tiep Nguyen; Hubertus Jarry
Journal:  Mol Cell Endocrinol       Date:  2013-11-22       Impact factor: 4.102

10.  Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction.

Authors:  Giovanni Corona; Matteo Monami; Valentina Boddi; Michela Cameron-Smith; Alessandra D Fisher; Giulia de Vita; Cecilia Melani; Daniela Balzi; Alessandra Sforza; Gianni Forti; Edoardo Mannucci; Mario Maggi
Journal:  J Sex Med       Date:  2010-01-25       Impact factor: 3.802

View more
  7 in total

Review 1.  Sex differences in renal mitochondrial function: a hormone-gous opportunity for research.

Authors:  Regina F Sultanova; Ryan Schibalski; Irina A Yankelevich; Krisztian Stadler; Daria V Ilatovskaya
Journal:  Am J Physiol Renal Physiol       Date:  2020-11-02

Review 2.  Impaired Exercise Tolerance in Heart Failure: Role of Skeletal Muscle Morphology and Function.

Authors:  Wesley J Tucker; Mark J Haykowsky; Yaewon Seo; Elisa Stehling; Daniel E Forman
Journal:  Curr Heart Fail Rep       Date:  2018-12

3.  Combined Lipidomics and Network Pharmacology Study of Protective Effects of Salvia miltiorrhiza against Blood Stasis Syndrome.

Authors:  Yidian Jin; Zhiru Xie; Shasha Li; Xiangyu Zeng; Leqi Wang; Ping Hu; Hongyang Zhang; Xue Xiao
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-19       Impact factor: 2.629

4.  Sex-Specific Associations of Testosterone and Genetic Factors With Health Span.

Authors:  Xiaoyu Zhao; Shuang Liang; Nanxi Wang; Tongtong Hong; Muhammed Lamin Sambou; Jingyi Fan; Meng Zhu; Cheng Wang; Dong Hang; Yue Jiang; Juncheng Dai
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-25       Impact factor: 5.555

Review 5.  Low Testosterone Level and Risk of Adverse Clinical Events among Male Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Cohort Studies.

Authors:  Li Li; Huixiang Ju; Hao Jin; Hongmei Chen; Mingzhong Sun; Zhongwei Zhou
Journal:  J Healthc Eng       Date:  2022-09-10       Impact factor: 3.822

Review 6.  Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart.

Authors:  Cinzia Perrino; Péter Ferdinandy; Hans E Bøtker; Bianca J J M Brundel; Peter Collins; Sean M Davidson; Hester M den Ruijter; Felix B Engel; Eva Gerdts; Henrique Girao; Mariann Gyöngyösi; Derek J Hausenloy; Sandrine Lecour; Rosalinda Madonna; Michael Marber; Elizabeth Murphy; Maurizio Pesce; Vera Regitz-Zagrosek; Joost P G Sluijter; Sabine Steffens; Can Gollmann-Tepeköylü; Linda W Van Laake; Sophie Van Linthout; Rainer Schulz; Kirsti Ytrehus
Journal:  Cardiovasc Res       Date:  2021-01-21       Impact factor: 10.787

7.  A reporter mouse for non-invasive detection of toll-like receptor ligands induced acute phase responses.

Authors:  Chun-Fang Huang; Shang-Yi Chiu; Hung-Wen Huang; Bing-Ho Cheng; Hsiu-Min Pan; Wei-Lun Huang; Hsiao-Hui Chang; Chia-Chi Liao; Si-Tse Jiang; Yu-Chia Su
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.